CETP and breast cancer: Raised HDL-cholesterol due to genetic variants in CETP was associated with raised total and ER-positive breast cancer risk, but only two of the 11 variants were individually associated with breast cancer at the nominal significance level and MR Egger implied absent effects (Supplementary Tables 2 and 6).